Amolyt Pharma

Scroll
Investment area
Novo Ventures
Region
Europe
Date of investment
July 2019
Website
https://amolytpharma.com/

Amolyt Pharma develops innovative therapeutic peptides for rare endocrine and metabolic diseases. Their ambition is to become a leading rare disease company with U.S. and European operations to support
global development of our products.